翻訳と辞書 |
sirukumab
Sirukumab (CNTO 136) is a human monoclonal antibody designed for the treatment of rheumatoid arthritis.〔(【引用サイトリンク】publisher=American Medical Association )〕 Sirukumab is currently under development by Johnson & Johnson's subsidiary Centocor.〔(Interleukin-6 Inhibitor Sirukumab (CNTO 136) Phase 2 Data Show Promise in the Treatment of Active Rheumatoid Arthritis )〕〔(A Study of the Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy ), clinicaltrials.gov〕 == References ==
〔
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「sirukumab」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|